rivoceranib
hlb bio group
['rivoceranib']
"a phase 2 study of the oral vascular endothelial growth factor receptor 2 (vegfr2) inhibitor, rivoceranib, for recurrent or metastatic (r/m) #adenoidcysticcarcinoma (acc)." 
I am only an ACC patient and not an expert at all.
The idea is simply to share the interesting articles I find and some good news to cheer us all up!